Post

New research · Dermatology
Journal of radiation research · 2d
StudyJournal of radiation research · 2026

Dosimetric feasibility of carbon-ion radiotherapy for ocular melanomas with local effect model-based treatment planning system.

Yuze Yang, Jiayao Sun, Xue Ming … Yinxiangzi Sheng
Read paper
DermatologyStudy

A conversion factor of 0.65 was needed to adapt carbon-ion radiotherapy dose planning for eye melanoma.

Dosimetric feasibility of carbon-ion radiotherapy for ocular melanomas with local effect model-based treatment planning system.

Yuze Yang … Yinxiangzi Sheng
Journal of radiation research · 2026
Purpose

This study evaluates the dosimetric feasibility of carbon-ion radiation therapy (carbon-ion radiation therapy) for ocular melanoma (ocular melanoma) using a local effect model-I-based treatment planning system (treatment planning system) combined with pencil beam scanning delivery.

0.65
Results
0.65
converts standard dose planning to match this therapy - lower means a smaller adjusted dose
More results

The 3D gamma passing rate between treatment planning system and MC was ≥94% using 3%-3 mm criteria.

Mean dose deviations between the treatment planning system and measurement were ≤±1.61% for all targets sizes except the smallest one (7 mm).

More results

Mean distance-to-agreement was <1 mm for all plans except one with a range shifter (distance-to-agreement = 2.92 mm).

Phantom cases showed a lateral penumbra of 5.4-6.2 mm, and distal dose fall-off measures 3.6 and 5.6 mm.

“
Conclusion

The results underscore the need for relative biological effectiveness-weighted dose conversion when applying Quantum Science and Technology's carbon-ion radiation therapy experience to ocular melanoma treatment.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
AI / Informatics
0·962 for OCT
MerMED-FM was very accurate at diagnosing diseases using eye scans
Cohort Study
κ = 0.211
confocal and dermoscopy diagnoses agreed only fair, not reliably interchangeable
Cohort Study
48%
nearly half never started treatment their surgeon recommended
Cohort Study
HR 1.06
6% higher rate of non-melanoma skin cancer with GLP-1 drugs versus SGLT2 inhibitors; effect faded after bias correction.
AI / Informatics
0.98
Artificial intelligence's eyelid-height measurements matched doctors' manual measurements almost perfectly
AI / Informatics
92.1%
combining eye scans and photos correctly told benign from cancerous lesions apart nearly every time
Cohort Study
28.6%
recurred locally in more than 1 in 4 patients over years of follow-up
Cohort Study
-0.395
excision group's post-op eyelid fullness score was lower - greater improvement